Clinical Trials on Paraproteinemias in United Kingdom
Total 2367 results
-
Oxford University Hospitals NHS TrustRecruiting
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
King's College Hospital NHS TrustCompleted
-
University College, LondonCompleted
-
Royal Marsden NHS Foundation TrustCompleted
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruitingMultiple MyelomaUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; National Institute for...Completed
-
University of LeedsMerck Sharp & Dohme LLC; Myeloma UKCompletedMultiple MyelomaUnited Kingdom
-
Becton, Dickinson and CompanyCompletedPlasma Cell DisorderSwitzerland, Spain, United Kingdom, United States, Portugal
-
Royal National Orthopaedic Hospital NHS TrustTerminatedMultiple MyelomaUnited Kingdom
-
The Royal Wolverhampton Hospitals NHS TrustUniversity of WolverhamptonRecruiting
-
Sheffield Teaching Hospitals NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Royal Marsden NHS Foundation TrustCompleted
-
University of LiverpoolGenzyme, a Sanofi CompanyUnknownLymphoma | Lymphoproliferative Disorders | Multiple Myeloma | Plasma Cell DyscrasiaUnited Kingdom
-
University College, LondonCancer Research UKRecruitingMultiple Myeloma | MGUS | Smouldering MyelomaUnited Kingdom
-
The Christie NHS Foundation TrustCellCentric Ltd.Not yet recruitingMultiple MyelomaUnited Kingdom
-
Prof Jamie CavenaghNovartis; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
University College, LondonEnrolling by invitationMultiple MyelomaUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of CopenhagenActive, not recruiting
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruiting
-
Riverside Haematology GroupUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKWithdrawnMyeloma MultipleUnited Kingdom
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United KingdomActive, not recruiting
-
Medical Research CouncilUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Acerta Pharma BVAcerta Pharma, LLCCompletedMultiple Myeloma (MM)United States, United Kingdom
-
The Christie NHS Foundation TrustNot yet recruiting
-
Medical Research CouncilUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
CASI Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited Kingdom, France
-
Marianna FontanaRecruitingExploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders (EXACLIBUR)Sudden Cardiac Death | Arrythmia | Cardiac Amyloidosis | Systemic AL AmyloidosisUnited Kingdom
-
Autolus LimitedTerminatedMultiple MyelomaUnited Kingdom, Netherlands
-
Sirtris, a GSK CompanyGlaxoSmithKlineTerminatedMultiple MyelomaUnited Kingdom, Denmark
-
University of SouthamptonNIHR Clinical Research Facility, University Hospital Southampton NHS Foundation... and other collaboratorsTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
University Hospital BirminghamOrtho Biotech, Inc.; Gambro Renal Products, Inc.CompletedMultiple Myeloma | Kidney Failure | Cast NephropathyUnited Kingdom
-
Oxford University Hospitals NHS TrustAmgenCompletedMyeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)United Kingdom
-
Chroma TherapeuticsCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Verastem, Inc.; Chugai PharmaceuticalRecruitingMultiple Myeloma | Ovarian Cancer | Lung Cancer | Solid TumoursUnited Kingdom
-
University Hospitals of North Midlands NHS TrustCompletedMultiple MyelomaUnited Kingdom
-
St. Bartholomew's HospitalUnknownLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Anaveon AGRecruitingLung Cancer | Advanced Solid Tumor | Adult DiseaseUnited Kingdom, Switzerland, Spain
-
European Myeloma NetworkGlaxoSmithKlineRecruitingAL AmyloidosisGermany, Netherlands, France, Greece, Italy, United Kingdom
-
The Christie NHS Foundation TrustCompletedBreast Cancer | Multiple Myeloma | Gastrointestinal Cancer | Gynaecological CancerUnited Kingdom
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Autolus LimitedEnrolling by invitationMultiple Myeloma | DLBCL | T Cell Lymphoma | Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy | ALL, Adult and PediatricUnited Kingdom
-
GlycoMimetics IncorporatedCompletedMultiple MyelomaIreland, Denmark, United Kingdom, Germany
-
University of LeedsMillennium Pharmaceuticals, Inc.; Myeloma UKUnknown
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
CelgeneCompletedMultiple MyelomaUnited Kingdom, France
-
Cancer Trials IrelandCompleted